Biomarkers for predicting nucleos(t)ide analogs discontinuation and hepatitis B virus recurrence after drug withdrawal in chronic hepatitis B patients-Reference-Cited by-同舟云学术

Biomarkers for predicting nucleos(t)ide analogs discontinuation and hepatitis B virus recurrence after drug withdrawal in chronic hepatitis B patients

Published:2022-02-21 Issue:4 Volume:52 Page:337-351
ISSN:1386-6346
Container-title:Hepatology Research
language:en
Short-container-title:Hepatology Research

Author:

Luo Mengqi¹,Zhou Bin¹,Hou Jinlin¹,Jiang Deke¹

Affiliation:

1. Department of Infectious Diseases and Hepatology Unit State Key Laboratory of Organ Failure Research Guangdong Key Laboratory of Viral Hepatitis Research Institutes of Liver Diseases Research of Guangdong Province Nanfang Hospital Southern Medical University Guangzhou China

Publisher

Wiley

Subject

Infectious Diseases,Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/hepr.13749

Reference98 articles.

1. Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study

2. EASL‐AASLD HBV treatment endpoints Conference FacultyGuidance for design and endpoints of clinical trials in chronic hepatitis B ‐ report from the 2019 EASL‐AASLD HBV treatment endpoints Conference;Cornberg M;Hepatology,2019

3. Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance

4. EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection

5. Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The impact of integrated hepatitis B virus DNA on oncogenesis and antiviral therapy;Biomarker Research;2024-08-15

2. High end‐of‐treatment hepatitis B core‐related antigen levels predict hepatitis flare after stopping nucleot(s)ide analogue therapy;Liver International;2024-07-15

3. Quantitative Measurement of Serum HBcrAg Can Be Used to Assess the Feasibility of Safe Discontinuation of Antiviral Therapy for Chronic Hepatitis B;Viruses;2024-03-29

4. When to Stop Antiviral Therapy in HBeAg-Negative Patients with Chronic Hepatitis B?;Current Hepatology Reports;2024-02-23

5. Serum RNase L levels in patients with chronic hepatitis B virus infection;Hepatology Research;2023-11